Tizanidine
- Product NDC
- 60760-263
- 11-digit product format
- 607600263
- Labeler code
- 60760
- Product ID
- 60760-263_8abd00cd-9256-da09-e053-2995a90aa39c
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Tizanidine
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- St. Mary's Medical Park Pharmacy
- Application
- ANDA091283
- Marketing category
- ANDA
- Marketing start
- 2018-07-19
- Marketing end
- 0000-00-00
- Substance
- TIZANIDINE HYDROCHLORIDE
- Active strength
- 4 mg/1
- Pharmacologic classes
- Adrenergic alpha2-Agonists [MoA],Central alpha-2 Adrenergic Agonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2020-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 60760-263-04 | 60760026304 | 4 TABLET in 1 BOTTLE, PLASTIC (60760-263-04) | 4 tablet | 2019-05-17 | 0000-00-00 | No | No | Current |
| 60760-263-15 | 60760026315 | 15 TABLET in 1 BOTTLE, PLASTIC (60760-263-15) | 15 tablet | 2018-07-19 | 0000-00-00 | No | No | Current |
| 60760-263-30 | 60760026330 | 30 TABLET in 1 BOTTLE, PLASTIC (60760-263-30) | 30 tablet | 2018-08-21 | 0000-00-00 | No | No | Current |
| 60760-263-60 | 60760026360 | 60 TABLET in 1 BOTTLE, PLASTIC (60760-263-60) | 60 tablet | 2019-06-07 | 0000-00-00 | No | No | Current |
| 60760-263-90 | 60760026390 | 90 TABLET in 1 BOTTLE, PLASTIC (60760-263-90) | 90 tablet | 2018-09-05 | 0000-00-00 | No | No | Current |